UncategorizedGenetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance 6 days ago01 mins GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. read more Post navigation Previous: Intel Strengthens Ties with China, Invests $300 Million to Expand Chip OperationsNext: Roku Q3 Earnings Preview: Can Platform Revenue Growth Exceed Expectations? Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday 2 hours ago 0